Stuart Chaussee & Associates’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-50
Closed -$7.32K 168
2025
Q3
$7.32K Hold
50
﹤0.01% 158
2025
Q2
$7.8K Hold
50
﹤0.01% 155
2025
Q1
$8.23K Hold
50
﹤0.01% 158
2024
Q4
$8.15K Hold
50
﹤0.01% 155
2024
Q3
$9.77K Hold
50
﹤0.01% 131
2024
Q2
$8.67K Hold
50
﹤0.01% 130
2024
Q1
$8.46K Hold
50
﹤0.01% 128
2023
Q4
$9.87K Hold
50
﹤0.01% 116
2023
Q3
$8.7K Hold
50
﹤0.01% 97
2023
Q2
$8.61K Hold
50
﹤0.01% 98
2023
Q1
$8.32K Hold
50
﹤0.01% 97
2022
Q4
$7.33K Hold
50
﹤0.01% 113
2022
Q3
$7K Hold
50
0.02% 108
2022
Q2
$9K Hold
50
0.02% 102
2022
Q1
$9K Sell
50
-58
-54% -$11.5K ﹤0.01% 126
2021
Q4
$26K Hold
108
0.01% 69
2021
Q3
$21K Hold
108
0.03% 64
2021
Q2
$20K Hold
108
0.01% 71
2021
Q1
$17K Buy
+108
New +$17.1K 0.01% 97

Other funds holding ZTS

Stuart Chaussee & Associates's ZTS Position: Q4 2025 in Review

Stuart Chaussee & Associates sold out of Zoetis (ZTS) in Q4 2025, closing a stake of 50 shares — an estimated $7.32K sold.

Stuart Chaussee & Associates first reported a position in ZTS in Q1 2021 and held it in 19 quarters. The position peaked at $26K in Q4 2021. 1,682 funds tracked by Wall St. Rank hold ZTS as of Q4 2025.

  • Stuart Chaussee & Associates reported no remaining Zoetis position as of Q4 2025 after selling out during the quarter.
  • Stuart Chaussee & Associates sold 50 Zoetis shares in Q4 2025, an estimated $7.32K.
  • Stuart Chaussee & Associates first reported a position in Zoetis in Q1 2021 and held it in 19 quarters.
  • Stuart Chaussee & Associates's Zoetis position peaked at $26K in Q4 2021.
  • 1,682 funds tracked by Wall St. Rank held Zoetis as of Q4 2025.

Based on Stuart Chaussee & Associates's 13F filing for Q4 2025.